Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Jul;14(1):137–143. doi: 10.1128/aac.14.1.137

Metabolic Fate of SCE-129, a New Antipseudomonal Cephalosporin, After Parenteral Administration in Rats and Dogs

Shigeharu Tanayama 1, Kiyoshi Yoshida 1, Yoshio Kanai 1
PMCID: PMC352417  PMID: 686704

Abstract

Disposition of [14C]SCE-129 was studied in rats and dogs after intramuscular (i.m.) or intravenous (i.v.) injection. In rats, the plasma level of i.m. [14C]SCE-129 attained a peak at 15 min after dosing and then declined with a half-life of 35 min, whereas the half-life after an i.v. dose was 26 min. The area under the plasma level curve within 2 h after the i.m. dose was 85% of that after the i.v. dose. Intramuscular injection of [14C]SCE-129 into dogs gave a peak plasma level at 30 min and a half-life of 60 min. In both rats and dogs, the plasma levels of 14C were closely similar to those of the unchanged antibiotic, which was weakly bound to plasma protein. The rat tissue level of i.m. [14C]SCE-129 was maximum at 15 min, with the highest concentration in the kidney, followed by plasma, adrenal, lung, heart, thymus, gastrointestinal wall, and liver, and the lowest in the brain. The antibiotic barely entered erythrocytes of rats and dogs. Whole-body autora-diographic studies showed that i.m. [14C]SCE-129 scarcely crossed the rat placenta. 14C was detected in the milk of rats given i.m. [14C]SCE-129. In both rats and dogs, almost all of the dosed 14C was excreted in urine within 24 h as the unaltered antibiotic, with only small amounts appearing in feces via bile. Thus, these findings evidenced a rapid absorption and wide distribution of i.m. SCE-129, followed by extensive renal elimination as the unaltered antibiotic.

Full text

PDF
137

Images in this article

141Image
on p.141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gillette J. R. Factors affecting drug metabolism. Ann N Y Acad Sci. 1971 Jul 6;179:43–66. doi: 10.1111/j.1749-6632.1971.tb46890.x. [DOI] [PubMed] [Google Scholar]
  2. Hoehn M. M., Murphy H. W., Pugh C. T., Davis N. E. Paper chromatographic techniques for the determination of cephalothin and desacetylcephalothin in body fluids. Appl Microbiol. 1970 Nov;20(5):734–736. doi: 10.1128/am.20.5.734-736.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kozatani J., Okui M., Noda K., Ogino T., Noguchi H. Cefazolin, a new semisynthetic cephalosporin antibiotic. V. Distribution of cefazolin- 14 C in mice and rats after parenteral administration. Chem Pharm Bull (Tokyo) 1972 Jun;20(6):1105–1113. doi: 10.1248/cpb.20.1105. [DOI] [PubMed] [Google Scholar]
  4. LEE C. C., HERR E. B., Jr, ANDERSON R. C. Pharmacological and toxicological studies on cephalotin. Clin Med (Northfield) 1963 Jun;70:1123–1138. [PubMed] [Google Scholar]
  5. MacAulay M. A., Charles D. Placental transfer of cephalothin. Am J Obstet Gynecol. 1968 Apr;100(7):940–946. doi: 10.1016/s0002-9378(15)33753-4. [DOI] [PubMed] [Google Scholar]
  6. Matsuzaki M., Matsumoto H., Ochiai K., Tashiro Y., Hino M. [Absorption, distribution and excretion of 14C-cefatrizine (14C-S-640 P) in rat (author's transl)]. Jpn J Antibiot. 1976 Apr;29(4):391–402. [PubMed] [Google Scholar]
  7. McCloskey R. V., Terry E. E., McCracken A. W., Sweeney M. J., Forland M. F. Effect of hemodialysis and renal failure on serum and urine concentrations of cephapirin sodium. Antimicrob Agents Chemother. 1972 Feb;1(2):90–93. doi: 10.1128/aac.1.2.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Nakai Y., Kanai Y., Fugono T., Tanayama S. Metabolic fate of cephacetrile after parenteral administration in rats and rabbits. J Antibiot (Tokyo) 1976 Jan;29(1):81–90. doi: 10.7164/antibiotics.29.81. [DOI] [PubMed] [Google Scholar]
  9. Nightingale C. H., Greene D. S., Quintiliani R. Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci. 1975 Dec;64(12):1899–1926. doi: 10.1002/jps.2600641202. [DOI] [PubMed] [Google Scholar]
  10. Nishida M., Murakawa T., Kamimura T., Okada N., Sakamoto H., Fukada S., Nakamoto S., Yokota Y., Miki K. In vitro and in vivo evaluation of ceftezole, a new cephalosporin derivative. Antimicrob Agents Chemother. 1976 Jul;10(1):1–13. doi: 10.1128/aac.10.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nishida M., Murakawa T., Kamimura T., Okada N., Sakamoto H. Laboratory evaluation of FR10612, a new oral cephalosporin derivative. J Antibiot (Tokyo) 1976 Apr;29(4):444–459. doi: 10.7164/antibiotics.29.444. [DOI] [PubMed] [Google Scholar]
  12. Shimizu K., Nishimura H. Problems in the bio-assay of orally administered cephaloglycin in biological fluids and method for the detection of its metabolite, desacetylcephaloglycin. J Antibiot (Tokyo) 1970 Apr;23(4):216–222. doi: 10.7164/antibiotics.23.216. [DOI] [PubMed] [Google Scholar]
  13. Sullivan H. R., Billings R. E., McMahon R. E. Metabolism of D-cephaloglycin-14C and L-cephaloglycin-14C in the rat. J Antibiot (Tokyo) 1969 Jan;22(1):27–33. doi: 10.7164/antibiotics.22.27. [DOI] [PubMed] [Google Scholar]
  14. Tanayama S., Fujita T., Shirakawa Y., Suzuoki Z. Metabolic fate of 5-ethoxycarbonyl-3-morpholinosydnonimine (SIN-10). 1. Absorption, excretion and tissue distribution in rats and mice. Jpn J Pharmacol. 1970 Sep;20(3):413–423. doi: 10.1254/jjp.20.413. [DOI] [PubMed] [Google Scholar]
  15. Tanayama S., Kanai Y. Studies on increased bile formation produced by polyoxybenzenes in rats. Jpn J Pharmacol. 1977 Feb;27(1):71–78. doi: 10.1254/jjp.27.71. [DOI] [PubMed] [Google Scholar]
  16. Tanayama S., Momose S., Kanai Y., Shirakawa Y. Metabolism of 8-chloro-6-phenyl-4H-s-triazolo(4,3-a)-(1,4)benzodiazepine (D-40TA), a new central depressant. IV. Placental transfer and excretion in milk in rats. Xenobiotica. 1974 Apr;4(4):219–227. doi: 10.3109/00498257409062540. [DOI] [PubMed] [Google Scholar]
  17. Tanayama S., Shirakawa Y., Kanai Y., Suzuoki Z. Metabolism of 8-chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)-benzodiazepine (D-40TA), a new central depressant. I. Absorption, distribution and excretion in rats. Xenobiotica. 1974 Jan;4(1):33–47. doi: 10.3109/00498257409052088. [DOI] [PubMed] [Google Scholar]
  18. Tsuchiya K., Kondo M., Nagatomo H. SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother. 1978 Feb;13(2):137–145. doi: 10.1128/aac.13.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. ULLBERG S. Studies on the distribution and fate of S35-labelled benzylpenicillin in the body. Acta Radiol Suppl. 1954;118:1–110. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES